Development Story: Dead-end
February 5, 2020
In the previous blog post about our development as a product and business, I was writing about how we started, how we failed and how
Category: Vision Therapy
Read More »
AmblyoPlay received the Audience Award at Health Venture Lab
January 15, 2020
AmblyoPlay is the recipient of the prestigious Audience Award from Health Venture Lab in Budapest, Hungary. It has been voted as the most convincing of
Development Story: The Beginning
November 22, 2019
Reading our blog posts, you can learn a lot about our eyes and especially about lazy eye – why it appears and how we tackle
Convergence Insufficiency and how to treat it!
November 13, 2019
An inability or decreased ability to converge the eyes whilst focusing on a near object is described as convergence insufficiency. Those who suffer from convergence
Binocular vision training as an active treatment of lazy eye!
October 17, 2019
We have already discussed active treatment options for amblyopia in general in one of our previous blogs and we will now go into further details
Amblyopia treatment: Development through the ages
October 7, 2019
The word amblyopia derives from the Greek words ‘ambly’ which means dull and ‘ops’ that means vision, hence ‘amblyopia’, or in translation the ‘dullness of
The importance of compliance for lazy eye treatment
September 30, 2019
Probably most of the parents, if not all, who have a child diagnosed with amblyopia are facing or have been facing an important issue when
VISIT US AT VISION EXPO WEST IN LAS VEGAS!
September 2, 2019
Following our official launch to the U.S. market last week, we are continuing the process of becoming a household name for the field of vision
AmblyoPlay Vision Therapy for Lazy Eye available in the U.S.
August 29, 2019
SAN FRANCISCO – Aug. 27, 2019 – AmblyoPlay, a home-based vision therapy solution for children and adults with amblyopia (lazy eye), mild strabismus (crossed or
Active treatment options for amblyopia
August 6, 2019
It is fair to say that we have come a long way in terms of addressing amblyopia. Having been discovered early enough in its course